Patent ID: 9555012
Date: 2017-01-31
CPC Classifications: A61K,A61P

Claim:
1. A method of treating muscle weakness or increasing muscle strength in a subject in need thereof, the method comprising administering to the subject an effective amount of meglumine or a salt thereof as the single active agent; whereby administration of the meglumine or salt thereof treats muscle weakness in the subject, or increases muscle strength in the subject, and wherein the meglumine salt is formed between meglumine and an acid selected from the group consisting of sulfate, hydrogen sulfate, hydrochloric, hydrobromic, hydriodic, nitric, carbonic, sulfuric, phosphoric, formic, acetic, propionic, succinic, glycolic, gluconic, lactic, malic, tartaric, citric, ascorbic, glucuronic, maleic, fumaric, pyruvic, aspartic, glutamic, benzoic, anthranilic, 4-hydroxybenzoic, phenylacetic, mandelic, embonic, methanesulfonic, ethanesulfonic, benzenesulfonic, pantothenic, trifluoromethanesulfonic, 2-hydroxyethanesulfonic, p-toluenesulfonic, sulfanilic, cyclohexylaminosulfonic, stearic, alginic, β-hydroxybutyric, salicylic, galactaric, and galacturonic acid.